Navigation Links
Venous origin of the mammalian lymphatic vasculature
Date:9/30/2007

In the October 1 issue of G&D, Dr. Guillermo Oliver (St. Jude Childrens Research Hospital) and colleagues present new evidence to resolve a century-old debate over the origin of the mammalian lymphatic vasculature. Understanding the development of the lymphatic vasculature is integral to understanding its function in both health (mediating immunity and maintaining tissue fluid levels) and disease (lymphedema and spreading tumor metastasis).

The adult mammalian lymphatic vasculature is derived from a few embryonic lymph sacs. The debate has surrounded the cellular origin of the lymphatic vasculature: Does it arise from venous endothelial cells or does it arise in the mesenchyme and then establish venous connection later on in development"

Dr. Oliver and colleagues used genetically modified mice to perform elegant lineage tracing experiments, from which they concluded, quite definitively, that the mammalian lymphatic vasculature is venous-derived.

Identifying the origin of any specific cell type is critical to understand the basic processes guiding the development of an organ. The detailed characterization of the formation of a normal healthy lymphatic vasculature is central to our efforts to prevent, diagnose, and hopefully cure lymphatic vasculature disorders, explains Dr. Oliver.


'/>"/>

Contact: Heather Cosel
coselpie@cshl.edu
Cold Spring Harbor Laboratory
Source:Eurekalert

Page: 1

Related biology news :

1. Study shows pine bark naturally decreases severe chronic venous insufficiency
2. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
3. Intravenous nanoparticle gene therapy shows activity in stage IV lung cancer
4. UAB scientists discover the origin of a mysterious physical force
5. An (ecological) origin of species for tropical reef fish
6. Ancient DNA helps clarify the origins of two extinct New World horse species
7. International Team Determines Geographic Origin of Leprosy
8. The genetic origins of corn on the cob
9. New Look at DNA Hints at Origin of UV Damage
10. Scientists discover stem cell origin of neck and shoulders
11. Tulane researcher reports on origin of deadly fever outbreak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)A coating on windows or solar panels that repels grime and dirt? Expanded battery storage capacities for the next electric car? New Tel Aviv University research, just published in Nature Nanotechnolo
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
(Date:12/3/2009)Have you ever felt overly upset by a social snubbing? Your genetics, not your friends, may be at fault. , Scientists have long known that opium-like painkillers, called opioids, relieve not only phys
Breaking Biology News(10 mins):A window that washes itself? 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3New research suggests how low doses of radiation can cause heart disease and stroke 59969 1New research suggests how low doses of radiation can cause heart disease and stroke 59969 2Ethiopias climate 27 million years ago had higher rainfall warmer soil 10491 1Ethiopias climate 27 million years ago had higher rainfall warmer soil 10491 2Syphilis survey reveals need for accurate testing for early infection 59960 1
...eath among American men. It is estimated ...se during his lifetime. However, promising new tre...this threatening disease. , One of the most innova...oscopic prostatectomy (removal of the prostate). T...rently one of only a handful of fac...
... vitro fertilization offers couples the best chanc...potentially cause doctors to misdiagnose a small f... say. , Citing concerns about the accuracy of pre...actitioners use to pick the healthiest embryos dur...dure. Their work, described during a recent meetin...
...stem of adult mice appear to play a role in the br... olfactory neurons are especially sensitive to nov...new odors. This level of flexibility suggests tha... adapt to and integrate into other regions of the ...st to injury or disease. The report from research...
Other Biology News:Penn Surgeons Use Completely Robotic Surgery to Successfully Treat Prostate Cancer 2Penn Surgeons Use Completely Robotic Surgery to Successfully Treat Prostate Cancer 3Genetic testing still smart choice, despite uncertainties 2Genetic testing still smart choice, despite uncertainties 3Neurons generated in the adult brain learn to respond to novel stimuli 2
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
(Date:12/2/2009)SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through,extraordinary times; markets are in turmoil and uncertainty is part of many,businesses and industries. It turns out that the pharma ind
(Date:12/1/2009)INCLINE VILLAGE, Nev., Dec. 1 PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced revenue guidance for the fourth quarter ended December 31, 2009 of approximately $57 million, as compared with
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...c. (NYSE: CRY ),a biomaterials, medical device an...it is scheduled to participate in the 19th Annual ... Hotel in New York City on Tuesday,November 27, 20...Life, Inc. will deliver,the Company,s presentation...fe,s live presentation may be accessed through its...
...re/ - Cytochroma Inc. announced today,that it has ... CTAP101,Capsules, the Company,s product candidate...hronic kidney disease (CKD). This Phase I/II clin...ed to establish the pharmacokinetic profile and sa...D insufficiency. The product,s,pharmacokinetic pro...
... Third quarter Consolidated Net Income NIS 178 Mil...Quarter 2006 Results Adversely Affected by,Norther...raft Prospectus for the Issue of,Debentures Primar...tures,Were Rated AA Stable by Maalot, a Standard a...ORL) ("Oil Refineries" or the "Company"),announced...
Other Biology Technology:CryoLife to Present at 19th Annual Piper Jaffray Health Care Conference in New York 2Cytochroma initiates Phase I/II clinical trial of CTAP101 Capsules for vitamin D insufficiency in chronic kidney disease 2Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 2Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 3Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 4Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 5Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 6Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 7Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 8Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 9Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 10Oil Refineries Announces Financial Results for Third Quarter and Nine Months 2007 11
...Microarray is specifically designed for location a...ins by pairing chromatin immunoprecipitation (ChIP...robust hybridization and reliable binding data wit...tives. In addition, Agilent provides flexibility b...
...ore user-friendliness and absolute reliability uni...ion of the Mastercycler ep system. In the past few...ynamically. The same applies to the capabilities r...echnological advances, the challenges of tomorrow ...
...s-based research with S. aureus, Sigma-Genosys has...at contains PCR primers to amplify all open readin...rimer pairs are included to amplify ORFs that are ...eus. The ORFmer set contains primers to amplify al...
...Handler is a high-capacity, plug-and-play bench to...ers, readers and liquid handling systems together ...ibility and intuitive and powerful software. Wheth...nking several modules together to complete a robot...
Biology Products: